SuperworthCompass Therapeutics market cap CMPX
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $137M
- Highest close in our data
- $1.2B
- Feb 2026
Compass Therapeutics is worth $137M at the close on Oct 23, 2026, at $0.76 a share.
That is down 75% over the last year and down 26% over five years.
Its highest close in our data was $1.2B in Feb 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $137M | $137M | $1.2B | −85% |
| 2025 | $919.5M | $201.9M | $1B | +358% |
| 2024 | $200.9M | $110.1M | $293.1M | +1% |
| 2023 | $198.9M | $197.6M | $654.9M | −69% |
| 2022 | $634.7M | $127.4M | $682.7M | +104% |
| 2021 | $310.8M | $186.3M | $458.6M | n/a |
Against its peers
Companies in Healthcare nearest Compass Therapeutics' size, closest first, today.
| Company | Market cap |
|---|---|
| CMPXCompass Therapeutics | $137M |
| KEQUKewaunee Scientific | $94.9M |
| PDEXPro DEX | $199.3M |
| ICCCImmucell | $93.1M |
| PLXProtalix BioTherapeutics | $205.5M |
| NATRNatures Sunshine Products | $213.8M |
| ELMDElectromed | $220.6M |
| UTMDUtah Medical Products | $236.3M |
| LFVNLifevantage | $73.4M |
| INFUInfuSystem | $277.6M |
| SPROSpero Therapeutics | $64.6M |
| Peer median | $202.4M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Compass Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.